SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062923
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:42
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-20230930.htm   iXBRL 10-Q 2780183
2 EX-31.1 ubx-ex31_1.htm EX-31.1 18663
3 EX-31.2 ubx-ex31_2.htm EX-31.2 18645
4 EX-32.1 ubx-ex32_1.htm EX-32.1 18377
  Complete submission text file 0000950170-23-062923.txt   9761917

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ubx-20230930_cal.xml EX-101.CAL 52873
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ubx-20230930_def.xml EX-101.DEF 248281
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ubx-20230930_pre.xml EX-101.PRE 387306
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ubx-20230930_lab.xml EX-101.LAB 526462
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ubx-20230930.xsd EX-101.SCH 72205
63 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20230930_htm.xml XML 1626836
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 231398665
SIC: 2834 Pharmaceutical Preparations